Human ENA-78 (CXCL5) Recombinant
$70.00 – $2,700.00
| accession | P42830 |
| Source | Optimized DNA sequence encoding Human ENA-78 (CXCL5) mature chain was expressed in Escherichia Coli. |
| Molecular weight | Human ENA-78, generated by the proteolytic removal of the signal peptide and propeptide and has a calculated molecular mass of approximately8 kDa. RecombinantCXCL5 is a monomeric protein consisting of 75 amino acid residue subunits and migrates as an approximately8 kDa protein under non-reducing conditions and reducing conditions in SDS-PAGE. |
| Purity | >98%, as determined by SDS-PAGE and HPLC |
| Biological Activity | Determined by its ability to chemoattract human neutrophils using a concentration range of 2.0-40.0 ng/ml. |
| Protein Sequence | |
| Endotoxin | Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than 0.1 ng/µg(1EU/µg). |
| Presentation | Recombinant ENA-78 was lyophilized from a 0.2 μm filtered 20mM PB,100mM NaCl solution pH 7.5. |
| Reconstitution | A quick spin of the vial followed by reconstitution in distilled water to a concentration not less than 0.1 mg/mL. This solution can then be diluted into other buffers. |
| Storage | The lyophilized protein is stable for at least 2 years from date of receipt at -20° C. Upon reconstitution, this cytokine can be stored in working aliquots at 2° - 8° C for one month, or at -20° C for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles. |
| Usage | This cytokine product is for research purposes only.It may not be used for therapeutics or diagnostic purposes. |
| Interactor | P25024 |
| Interactor | P25025 |
| Molecular function | Cytokine |